DCOY earnings: a positive outcome, +6.0%

On March 22, 2024, Salarius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.0% in the window around the event. It had already run +15.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.